This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
MACOM (MTSI) Q3 Earnings Match Estimates, Revenues Fall Y/Y
by Zacks Equity Research
MACOM's (MTSI) third-quarter fiscal 2023 results reflect sluggishness in the Telecommunications and Data Center markets.
Compared to Estimates, M/A-Com (MTSI) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for M/A-Com (MTSI) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
M/A-Com (MTSI) Q3 Earnings Meet Estimates
by Zacks Equity Research
M/A-Com (MTSI) delivered earnings and revenue surprises of 0% and 1%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Monolithic Power (MPWR) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Monolithic (MPWR) delivered earnings and revenue surprises of 0.36% and 0.15%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
MaxLinear (MXL) Q2 Earnings Beat Estimates
by Zacks Equity Research
MaxLinear (MXL) delivered earnings and revenue surprises of 3.03% and 3.21%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate M/A-Com (MTSI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
M/A-Com (MTSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MACOM (MTSI) Q2 Earnings & Revenues Top Estimates, Rise Y/Y
by Zacks Equity Research
MACOM's (MTSI) second-quarter fiscal 2023 results benefit from solid momentum across the Data center and Industrial and Defense markets.
Zacks.com featured highlights Sweetgreen, Adaptimmune Therapeutics, Owl Rock Capital, MACOM Technology Solutions and Equity Commonwealth
by Zacks Equity Research
Sweetgreen, Adaptimmune Therapeutics, Owl Rock Capital, MACOM Technology Solutions and Equity Commonwealth have been highlighted in this Screen of The Week article.
M/A-Com (MTSI) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
M/A-Com (MTSI) delivered earnings and revenue surprises of 2.60% and 0.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Forget Bargain Hunting, Buy 5 Stocks With Rising P/E
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include Sweetgreen (SG), Adaptimmune Therapeutics (ADAP), Owl Rock Capital (ORCC), MACOM Technology Solutions (MTSI) and Equity Commonwealth (EQC).
Magnachip (MX) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Magnachip (MX) delivered earnings and revenue surprises of 4% and 0.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Down -14.3% in 4 Weeks, Here's Why M/A-Com (MTSI) Looks Ripe for a Turnaround
by Zacks Equity Research
M/A-Com (MTSI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Here's Why M/A-Com (MTSI) is Poised for a Turnaround After Losing -11.97% in 4 Weeks
by Zacks Equity Research
M/A-Com (MTSI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Silicon Laboratories (SLAB) Meets Q1 Earnings Estimates
by Zacks Equity Research
Silicon Labs (SLAB) delivered earnings and revenue surprises of 0% and 0.51%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
5 Semiconductor Stock to Buy to Enhance Your Portfolio
by Nalak Das
We have narrowed our search to five semiconductor manufacturers. These are: LRCX, MCHP, ADI, MTSI and STM.
Semtech (SMTC) Q4 Earnings Lag Estimates
by Zacks Equity Research
Semtech (SMTC) delivered earnings and revenue surprises of -2.08% and 11.63%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Is Analog Devices (ADI) Down 3.7% Since Last Earnings Report?
by Zacks Equity Research
Analog Devices (ADI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Monolithic (MPWR) Down 3.5% Since Last Earnings Report?
by Zacks Equity Research
Monolithic (MPWR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MACOM (MTSI) Boosts Data Center Reach With New Product Family
by Zacks Equity Research
MACOM (MTSI) unveils 226Gbps per lane technology product family, which comprises transimpedance amplifiers, externally modulated laser driver and photodiode.
MACOM (MTSI) Acquires Linearizer, Expands Product Portfolio
by Zacks Equity Research
MACOM (MTSI) acquires Linearizer, which is known for correcting distortion in communications systems and linear optical links.
ADI vs. MTSI: Which Stock Is the Better Value Option?
by Zacks Equity Research
ADI vs. MTSI: Which Stock Is the Better Value Option?
ADI or MTSI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ADI vs. MTSI: Which Stock Is the Better Value Option?
MACOM (MTSI) Q1 Earnings & Revenues Top Estimates, Rise Y/Y
by Zacks Equity Research
MACOM's (MTSI) first-quarter fiscal 2023 results benefit from solid momentum across the Telecom market, Data center, and industrial and defense markets.
M/A-Com (MTSI) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
M/A-Com (MTSI) delivered earnings and revenue surprises of 2.53% and 0.35%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
MACOM (MTSI) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
MACOM's (MTSI) first-quarter fiscal 2023 results are likely to reflect strength in telecommunication, data center, industrial and defense markets amid supply chain disruptions.